PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A
about
Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilmsFocal Targeting of the Bacterial Envelope by Antimicrobial PeptidesStrategies and molecular tools to fight antimicrobial resistance: resistome, transcriptome, and antimicrobial peptidesAntibiotic development challenges: the various mechanisms of action of antimicrobial peptides and of bacterial resistancePseudomonas aeruginosa biofilms in cystic fibrosisThe two-component system CprRS senses cationic peptides and triggers adaptive resistance in Pseudomonas aeruginosa independently of ParRSThe Pseudomonas aeruginosa lipid A deacylase: selection for expression and loss within the cystic fibrosis airway.The MerR-like regulator BrlR impairs Pseudomonas aeruginosa biofilm tolerance to colistin by repressing PhoPQGenome analysis of a transmissible lineage of pseudomonas aeruginosa reveals pathoadaptive mutations and distinct evolutionary paths of hypermutatorsA divergent Pseudomonas aeruginosa palmitoyltransferase essential for cystic fibrosis-specific lipid A.Construction of a mini-Tn5-luxCDABE mutant library in Pseudomonas aeruginosa PAO1: a tool for identifying differentially regulated genes.Cationic antimicrobial peptide resistance in Neisseria meningitidis.The MisR/MisS two-component regulatory system influences inner core structure and immunotype of lipooligosaccharide in Neisseria meningitidis.A novel 3-deoxy-D-manno-octulosonic acid (Kdo) hydrolase that removes the outer Kdo sugar of Helicobacter pylori lipopolysaccharide.Teaching 'old' polymyxins new tricks: new-generation lipopeptides targeting gram-negative 'superbugs'.Proteus mirabilis pmrI, an RppA-regulated gene necessary for polymyxin B resistance, biofilm formation, and urothelial cell invasion.Substitution of the Bordetella pertussis lipid A phosphate groups with glucosamine is required for robust NF-kappaB activation and release of proinflammatory cytokines in cells expressing human but not murine Toll-like receptor 4-MD-2-CD14Attenuation of colistin bactericidal activity by high inoculum of Pseudomonas aeruginosa characterized by a new mechanism-based population pharmacodynamic model.Characterization of UDP-glucose dehydrogenase and UDP-glucose pyrophosphorylase mutants of Proteus mirabilis: defectiveness in polymyxin B resistance, swarming, and virulence.Colistin in the 21st century.Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system.Structure--activity relationships of polymyxin antibioticsMolecular characterization of the PhoPQ-PmrD-PmrAB mediated pathway regulating polymyxin B resistance in Klebsiella pneumoniae CG43.Serratia marcescens arn, a PhoP-regulated locus necessary for polymyxin B resistance.The role of Pseudomonas lipopolysaccharide in cystic fibrosis airway infectionStructural characterization of bacterial lipopolysaccharides with mass spectrometry and on- and off-line separation techniques.Bis-(3'-5')-cyclic dimeric GMP regulates antimicrobial peptide resistance in Pseudomonas aeruginosaAn orphan chemotaxis sensor regulates virulence and antibiotic tolerance in the human pathogen Pseudomonas aeruginosa.The PmrA-regulated pmrC gene mediates phosphoethanolamine modification of lipid A and polymyxin resistance in Salmonella enterica.Activity of cecropin A-melittin hybrid peptides against colistin-resistant clinical strains of Acinetobacter baumannii: molecular basis for the differential mechanisms of action.Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes.Impaired virulence and in vivo fitness of colistin-resistant Acinetobacter baumannii.Review: Lipopolysaccharide biosynthesis in Pseudomonas aeruginosa.Colistin and polymyxin B: peas in a pod, or chalk and cheese?Design, synthesis, and evaluation of a new fluorescent probe for measuring polymyxin-lipopolysaccharide binding interactionsPseudomonas aeruginosa: resistance to the maxThe pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A.The evolving dynamics of the microbial community in the cystic fibrosis lung.Two mechanisms of killing of Pseudomonas aeruginosa by tobramycin assessed at multiple inocula via mechanism-based modeling.The ferrous iron-responsive BqsRS two-component system activates genes that promote cationic stress tolerance.
P2860
Q21090518-C0E75555-EC8F-47C6-B699-69FAE8D82A94Q26744785-53C22F58-8040-451A-88FC-478B3AA74C54Q26861137-F2B7F1FE-EBD2-44C9-A04D-0C5A99928908Q26991811-CC35EFEE-1773-4084-AF07-EF34EB686487Q28299966-2C98F221-E145-4E6E-9A5E-A010E5B457B1Q28492572-4309BC14-5402-434C-AF87-95652A7E6C36Q28492613-E28216EE-6052-49DA-8B4D-E234A6F3CE3FQ28492677-FAAF1A3E-3FF7-4BBF-A439-D40A8A56A4C2Q28536866-80D0716D-0970-42F9-B962-B9A5C85CCFE3Q30153476-912C4736-8257-43C1-B589-AF6A3B522B7AQ30781626-24E45C0A-AB78-4056-873B-10DD2D9A0ED1Q30857151-E915BD25-8F4A-42D7-B583-CF898232D706Q31069986-66E1EC38-8F00-4ACD-A4D3-1004C8449D3FQ31167722-DFB80C18-A8CC-4DCD-9E6E-8F343AA96C1AQ33662378-37567DBA-3CC3-4080-9AF9-88F66169EF9FQ33768793-B5460A3C-5EAF-40AB-BE2B-C4A3E88EA074Q33825974-2E261B36-401C-4405-BE75-C5587FCC6BBAQ33826267-640FFDC2-6F65-44D8-9442-6C6760DA9AE4Q33826394-344B76C6-3CDA-4ADA-BF1F-925CC7B7ED50Q33847509-4C89051A-72F5-4854-8C6B-73999795165DQ33901939-16932FAB-ADD5-46E1-AADA-A217BAF85AEAQ34010143-4A976F54-1B1E-4B68-A955-BF3EC508A925Q34057293-2AF746AE-F526-4ED1-AC38-2D63F8707F92Q34057453-44EC8E42-CDE0-40C4-9602-D6ED0F3DB1C2Q34105561-5103174A-C2B7-4759-9E69-CE1D5A8247AFQ34312726-A010DC9B-12CF-4658-86C5-7A7F1805F6EEQ34327444-4E392931-B340-400F-920A-2F69C01B3360Q34369356-FB4CD7EE-71EB-4998-A30A-6D352ED12B35Q34434883-88DAD762-9CB9-4DF3-894B-0F3F6FC53194Q34510497-F8FCB643-A9A4-458E-B0D0-54E14D6F06D6Q34757004-958D13C8-8340-4536-843E-8AAB0AB2B33BQ34764355-7CEC87E9-2A54-4500-91B6-5E635C9DD097Q34999695-18676307-B7ED-4161-807A-5CC6E8200139Q35008357-E57E4035-C467-417F-A3E6-DD901E8D9128Q35019996-A2DF1B11-D3B3-4244-B3D0-1161F00B7298Q35084559-61B9E729-0332-419A-A344-71B62247AEA3Q35139454-A3CEB841-B196-42D5-BF34-43B0BAB53D30Q35163645-E3EA8461-BDC7-4CA3-82F3-1F39DBD8D88DQ35168882-2B65A177-018B-437D-AC92-CC7A0391EC68Q35172351-64379650-8429-4170-82C5-1104193FB3CF
P2860
PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
PmrAB, a two-component regulat ...... n of aminoarabinose to lipid A
@en
type
label
PmrAB, a two-component regulat ...... n of aminoarabinose to lipid A
@en
prefLabel
PmrAB, a two-component regulat ...... n of aminoarabinose to lipid A
@en
P2093
P2860
P1476
PmrAB, a two-component regulat ...... n of aminoarabinose to lipid A
@en
P2093
Robert K Ernst
Samuel I Miller
Samuel M Moskowitz
P2860
P304
P356
10.1128/JB.186.2.575-579.2004
P577
2004-01-01T00:00:00Z